Notification of Issue of Securities

23 September 2020 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited ("FPH") under the Fisher & Paykel Healthcare 2003 Share Option Plan. This notice is given in reliance on a waiver from NZX Listing Rule 3.13.1 granted by NZX on 6 August 2019 that allows FPH, subject to certain conditions, to disclose the issue of FPH shares under FPH's employee share purchase schemes within 10 business days of issue. Section 1: issuer information Name of issuer Fisher & Paykel Healthcare Corporation Limited NZX ticker code FPH Class of Financial Product Ordinary shares ISIN NZFAPE0001S2 Section 2: capital change details Number of issuances to which this notice relates Seven Number issued (1) 42,708 (2) 34,660 (3) 25,093 (4) 33,066 (5) 21,783 (6) 10,056 (7) 16,997 Total issued: 184,363 shares Nominal value (if any) Not applicable Issue price (1) NZD11.81 (14,639 shares); NZDnil (28,069 shares). (2) NZD9.82 (1,420 shares); NZD11.81 (13,052 shares); NZDnil (20,188 shares). (3) NZD11.81 (10,593 shares); NZDnil (14,500 shares). (4) NZD9.82 (2,160 shares); NZD11.81 (10,091 shares); NZDnil (20,815 shares). (5) NZD11.81 (12,848 shares); NZDnil (8,935 shares). (6) NZD11.81 (2,896 shares); NZD9.82 (880 shares); NZDnil (6,280 shares). (7) NZD9.82 (3,132 shares); NZD11.81 (8,569 shares); NZDnil (5,296 shares). Nature of the payment Not applicable Amount paid up (if not in full) In full Percentage of total class of Financial Products issued (1) 0.00742% (2) 0.00602% (3) 0.00436% (4) 0.00574% (5) 0.00378% (6) 0.00175% (7) 0.00295% For an issue of Convertible Financial Products or Options, the principal terms of Conversion Not applicable Reason for issue (1) Cancellation of 18,220 options and issue of 11,672 ordinary shares; exercise of 2,967 options under the FPH Share Option Plan and issue of 2,967 ordinary shares; exercise of 10,309 Performance Share Rights under the FPH Performance Share Rights Plan 2016 issue and issue of 10,309 Ordinary Shares; exercise of 17,760 Performance Share Rights under the FPH Performance Share Rights Plan 2017 issue and issue of 17,760 Ordinary Shares. (2) Cancellation of 17,092 options and issue of 11,010 ordinary shares; cancellation of 2,017 options and issue of 1,420 ordinary shares; exercise of 2,042 options under the FPH Share Option Plan and issue of 2,042 ordinary shares; exercise of 11,228 Performance Share Rights under the FPH Performance Share Rights Plan 2016 issue and issue of 11,228 ordinary shares; exercise of 8,960 Performance Share Rights under the FPH Performance Share Rights Plan 2017 issue and issue of 8,960 ordinary shares. (3) Cancellation of 14,507 options and issue of 9,293 ordinary shares; exercise of 1,300 options under the FPH Share Option Plan and issue of 1,300 ordinary shares; exercise of 6,896 Performance Share Rights under the FPH Performance Share Rights Plan 2016 issue and issue of 6,896 ordinary shares; exercise of 7,604 Performance Share Rights under the FPH Performance Share Rights Plan 2017 issue and issue of 7,604 ordinary shares. (4) Cancellation of 3,073 options and issue of 2,160 ordinary shares; cancellation of 14,665 options and issue of 9,427 ordinary shares; exercise of 664 options under the FPH Share Option Plan and issue of 664 ordinary shares; exercise of 3,709 Performance Share Rights under the FPH Performance Share Rights Plan 2016 issue and issue of 3,709 ordinary shares; exercise of 17,106 Performance Share Rights under the FPH Performance Share Rights Plan 2017 issue and issue of 17,106 ordinary shares. (5) Cancellation of 20,151 options and issue of 12,848 ordinary shares; exercise of 4,315 Performance Share Rights under the FPH Performance Share Rights Plan 2016 issue and issue of 4,315 ordinary shares; exercise of 4,620 Performance Share Rights under the FPH Performance Share Rights Plan 2017 issue and issue of 4,620 ordinary shares. (6) Cancellation of 3,439 options and issue of 2,176 ordinary shares; exercise of 880 options under the FPH Share Option Plan and issue of 880 ordinary shares; exercise of 720 options under the FPH Share Option Plan and issue of 720 ordinary shares; exercise of 3,183 Performance Share Rights under the FPH Performance Share Rights Plan 2016 issue and issue of 3,183 ordinary shares; exercise of 3,097 Performance Share Rights under the FPH Performance Share Rights Plan 2017 issue and issue of 3,097 ordinary shares. (7) Cancellation of 10,361 options and issue of 6,490 ordinary shares; cancellation of 4,565 options and issue of 3,132 ordinary shares; exercise of 831 options under the FPH Share Option Plan and issue of 831 ordinary shares; exercise of 1,248 options under the FPH Share Option Plan and issue of 1,248 ordinary shares; exercise of 2,501 Performance Share Rights under the FPH Performance Share Rights Plan 2016 issue and issue of 2,501 ordinary shares; exercise of 2,795 Performance Share Rights under the FPH Performance Share Rights Plan 2017 issue and issue of 2,795 ordinary shares. All cancellations are under the FPH Share Option Plan Cancellation Facility Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue. (1) 575,908,563 (2) 575,943,223 (3) 575,968,316 (4) 576,001,382 (5) 576,023,165 (6) 576,033,221 (7) 576,050,218 Total number of ordinary shares on issue as at the date of this notice after the issues disclosed in this notice: 576,050,218. In the case of an acquisition of shares, whether those shares are to be held as treasury stock Not applicable Specific authority for the issue Directors' resolution, Listing Rule 4.6 Terms or details of the issue The ordinary shares issued rank pari passu with the existing ordinary shares Date of issue (1) 15 September 2020 (2) 16 September 2020 (3) 17 September 2020 (4) 18 September 2020 (5) 21 September 2020 (6) 22 September 2020 (7) 23 September 2020 Section 3: authority for this announcement Name of person authorised to make this announcement Marcus Driller Contact phone number +64 9 574 0110 Contact email address marcus.driller@fphcare.co.nz Date of release via MAP 23 September 2020 End CA:00360275 For:FPH Type:SECISSUE Time:2020-09-23 17:18:03